companydata.dkcompanydata.dk

Wallentin Medical Consulting ApS: Financial statements 2022

CVR: 41746505

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

Wallentin Medical Consulting ApS (CVR 41746505) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 622,441 and a net result of DKK 467,919 compared with DKK 953,300 the year before. That is a decrease of 50% compared with the year before. Equity in the 2022 report amounted to DKK 516,297. The solvency ratio was 66.2%.

Gross Profit
DKK 622,441
Profit/Loss
DKK 467,919
Equity
DKK 516,297
Total Assets
DKK 780,258

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-622K468K516K-
2021-1.2M953K1.4M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Wallentin Medical Consulting ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Wallentin Medical Consulting ApS: The 2021 annual report is outMar 14, 2022

Wallentin Medical Consulting ApS has published its annual report for 2021. Gross profit came to DKK 1,245,845, and the net result was DKK 953,300.

About Wallentin Medical Consulting ApS

Wallentin Medical Consulting ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2020. The company is registered under the industry Alment praktiserende lægers aktiviteter. The management consists of Rikke Søjborg Wallentin. The company is owned by Rikke Søjborg Wallentin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 684,736 and a net result of DKK 527,610 compared with DKK 517,283 the year before. Equity in the 2025 report amounted to DKK 1,684,947.

Source: annual report 2025, Danish Business Authority

Other financial years